Patents by Inventor Paul Fredrickson

Paul Fredrickson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060189536
    Abstract: The invention provides methods and materials for treating the effects of nicotine. In particular, the invention provides methods that involve administering a neurotensin receptor (NTR) agonist to a mammal that has been exposed to nicotine. The NTR agonist typically is administered in an amount effective to diminish or abolish the effects that nicotine has on the treated mammal. NTR agonists that can be used in methods of the invention include neurotensin (NT) polypeptide analogs such as NT69L. The invention also provides compositions containing an NTR agonist in combination with other agents used to help overcome nicotine effects such as sensitization and dependence. The compositions provided herein can be used to treat the effects of nicotine, including hyperactivity, hypothermia, respiratory distress, and hypertension.
    Type: Application
    Filed: May 2, 2006
    Publication date: August 24, 2006
    Inventors: Elliott Richelson, Paul Fredrickson, Mona Boules
  • Patent number: 7087575
    Abstract: The invention provides methods and materials for treating the effects of nicotine. In particular, the invention provides methods that involve administering a neurotensin receptor (NTR) agonist to a mammal that has been exposed to nicotine. The NTR agonist typically is administered in an amount effective to diminish or abolish the effects that nicotine has on the treated mammal. NTR agonists that can be used in methods of the invention include neurotensin (NT) polypeptide analogs such as NT69L. The invention also provides compositions containing an NTR agonist in combination with other agents used to help overcome nicotine effects such as sensitization and dependence. The compositions provided herein can be used to treat the effects of nicotine, including hyperactivity, hypothermia, respiratory distress, and hypertension.
    Type: Grant
    Filed: July 18, 2002
    Date of Patent: August 8, 2006
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Elliott Richelson, Paul Fredrickson, Mona Boules
  • Publication number: 20040014651
    Abstract: The invention provides methods and materials for treating the effects of nicotine. In particular, the invention provides methods that involve administering a neurotensin receptor (NTR) agonist to a mammal that has been exposed to nicotine. The NTR agonist typically is administered in an amount effective to diminish or abolish the effects that nicotine has on the treated mammal. NTR agonists that can be used in methods of the invention include neurotensin (NT) polypeptide analogs such as NT69L. The invention also provides compositions containing an NTR agonist in combination with other agents used to help overcome nicotine effects such as sensitization and dependence. The compositions provided herein can be used to treat the effects of nicotine, including hyperactivity, hypothermia, respiratory distress, and hypertension.
    Type: Application
    Filed: July 18, 2002
    Publication date: January 22, 2004
    Inventors: Elliott Richelson, Paul Fredrickson, Mona Boules
  • Patent number: 5228407
    Abstract: A ridged inflatable boat is provided with cavities formed on the out-board side of the hull, between the hull and the surrounding pneumatic tube, whereby fastening hardware intended to either retain the pneumatic tube or above deck hardware, may pass through the hull, deck or gunwhale without puncturing the pneumatic tube.
    Type: Grant
    Filed: February 1, 1991
    Date of Patent: July 20, 1993
    Assignee: Barry Douglas Enterprises Ltd.
    Inventors: John L. Cummer, Jack W. Sarin, Paul Fredrickson, James P. Kindsvater, Stephen L. Davis